Ibogaine Trial Worth the Risk

By: One News

Television New Zealand

MAPS’ observational study of ibogaine-assisted therapy for addiction treatment in New Zealand is the focus of a 10-minute segment on Television New Zealand. Study investigator Geoff Noller, Ph.D., explains how the study could help find better treatments for people suffering from substance abuse, and New Zealand Community Alcohol and Drug Services (CADS) Director Susanna Galea says that the benefits of the research significantly outweigh the risks.

Watch the segment online at TVNZ.